Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Bridion
Active Ingredient: Sugammadex 100mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturers: NV Organon, Oss, The Netherlands
Organon (Ireland) Limited, Swords, Co. Dublin, Ireland
Product: Celsentri
Active Ingredient: Maraviroc 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Godecke GmbH, Freiburg, Germany
Product: Celsentri
Active Ingredient: Maraviroc 300mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Godecke GmbH, Freiburg, Germany
Product: Revlimid
Active Ingredient: Lenalidomide 10mg
Dosage Form: Capsule
New Zealand Sponsor: Celgene Pty Limited Quigg Partners
Manufacturers: Norwich Pharmaceuticals Inc, Norwich, New York, United States of America
Penn Pharmaceutical Services Limited, Tredegar, Gwent, United Kingdom
Product: Revlimid
Active Ingredient: Lenalidomide 15mg
Dosage Form: Capsule
New Zealand Sponsor: Celgene Pty Limited Quigg Partners
Manufacturers: Norwich Pharmaceuticals Inc, Norwich, New York, United States of America
Penn Pharmaceutical Services Limited, Tredegar, Gwent, United Kingdom
Product: Revlimid
Active Ingredient: Lenalidomide 25mg
Dosage Form: Capsule
New Zealand Sponsor: Celgene Pty Limited Quigg Partners
Manufacturers: Norwich Pharmaceuticals Inc, Norwich, New York, United States of America
Penn Pharmaceutical Services Limited, Tredegar, Gwent, United Kingdom
Product: Revlimid
Active Ingredient: Lenalidomide 5mg
Dosage Form: Capsule
New Zealand Sponsor: Celgene Pty Limited Quigg Partners
Manufacturers: Norwich Pharmaceuticals Inc, Norwich, New York, United States of America
Penn Pharmaceutical Services Limited, Tredegar, Gwent, United Kingdom
Dated this 10th day of October 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).